XML 32 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]    
Net income/(loss) $ 3,679 $ (2,481)
Depreciation and tooling amortization 3,775 3,774
Other amortization (554) (608)
Provision for/(Benefit from) credit losses and insurance losses 212 (107)
Pension and other postretirement employee benefits (“OPEB”) expense/(income) (Note 13) 612 (400)
Equity method investment dividends received in excess of (earnings)/losses and impairments 142 171
Foreign currency adjustments (97) 60
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments 163 7,974
Net (gain)/loss on changes in investments in affiliates (17) 146
Stock compensation 238 170
Provision for/(Benefit from) deferred income taxes 3 (1,160)
Decrease/(Increase) in finance receivables (wholesale and other) (1,473) (4,611)
Decrease/(Increase) in accounts receivable and other assets (1,793) (1,856)
Decrease/(Increase) in inventory (3,354) (2,507)
Increase/(Decrease) in accounts payable and accrued and other liabilities 6,134 3,180
Other 165 118
Net cash provided by/(used in) operating activities 7,835 1,863
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]    
Capital spending (3,729) (3,069)
Acquisitions of finance receivables and operating leases (26,231) (20,749)
Collections of finance receivables and operating leases 22,517 24,139
Purchases of marketable securities and other investments (4,860) (8,065)
Sales and maturities of marketable securities and other investments 7,584 11,257
Settlements of derivatives (32) 156
Payments to Acquire Equity Method Investments (1,047) (36)
Other (359) 509
Net cash provided by/(used in) investing activities (6,157) 4,142
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]    
Cash payments for dividends and dividend equivalents (3,794) (807)
Purchases of common stock 0 0
Net changes in short-term debt (658) 595
Proceeds from issuance of long-term debt 26,401 18,868
Payments of long-term debt (22,213) (24,697)
Other (197) (199)
Net cash provided by/(used in) financing activities (461) (6,240)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]    
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 66 (368)
Net increase/(decrease) in cash, cash equivalents, and restricted cash 1,283 (603)
Cash, cash equivalents, and restricted cash at beginning of period (Note 7) 25,340 20,737
Cash, cash equivalents, and restricted cash at end of period (Note 7) $ 26,623 $ 20,134